|
Press Releases |
|
 |
|
Thursday, April 21, 2022 |
|
医思健康料全年销售额超30亿港元 按年增逾35% |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然公布集团截止2022年3月31日(「年内」)销售额之预期表现。 more info >> |
|
醫思健康料全年銷售額超30億港元 按年增逾35% |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然公佈集團截止2022年3月31日(「年內」)銷售額之預期表現。 more info >> |
|
EC Healthcare expects sales volume to increase 35% Y-o-Y to no less than HK$3 billion for the Year |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the expected performance of the Group's sales volume for the Year ended 31 March 2022 (the "Year"). more info >> |
|
Thursday, April 7, 2022 |
|
医思健康收购兽医业务 进一步整合宠物服务市场 提升市场占有率 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,以现金代价15.75百万港元向一名在香港注册的兽医(「卖方」)收购一家在香港大埔经营兽医医院的目标公司(「目标公司」)75%已发行股本。 more info >> |
|
醫思健康收購獸醫業務 進一步整合寵物服務市場 提升市場佔有率 |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然宣佈,以現金代價15.75百萬港元向一名在香港註冊的獸醫(「賣方」)收購一家在香港大埔經營獸醫醫院的目標公司(「目標公司」)75%已發行股本。 more info >> |
|
EC Healthcare Acquires Veterinary Business, Further Consolidate the Pet Service Industry and Increase Market Shares |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group acquires 75% equity interests in a company operating veterinary hospital in Tai Po (the "Target Companies") from a registered veterinary surgeon in Hong Kong (The "Seller") for a total consideration of HK$15.75 million in cash more info >> |
|
Monday, April 4, 2022 |
|
医思健康新设中环综合医疗服务旗舰中心及太古高端影像中心 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,集团位于中环的综合医疗服务旗舰中心(「新旗舰中心」)及太古的高端影像中心,分别于2022年3月31日及2022年4月1日正式投入运营,集团在医疗领域的市场份额得以进一步扩大。 more info >> |
|
醫思健康新設中環綜合醫療服務旗艦中心及太古高端影像中心 |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然宣佈,集團位於中環的綜合醫療服務旗艦中心(「新旗艦中心」)及太古的高端影像中心,分別於2022年3月31日及2022年4月1日正式投入運營,集團在醫療領域的市場份額得以進一步擴大。 more info >> |
|
EC Healthcare Opens New Multi-Service Flagship Medical Centre at Central and Advanced Imaging Centre at Taikoo |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* more info >> |
|
Wednesday, March 9, 2022 |
|
医思健康推出遥距医疗及药物配送服务 减少外出感染风险 守护市民健康 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,为减少市民外出就医风险,集团旗下的医思健康医疗中心、智健康、汇儿儿科医务中心及纽约医疗集团的脊医及中医服务均推出遥距视像诊症服务。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Drilling at Congress Gold Mine Project Returns as high as 14.9 g/t Gold over 1.5m
Feb 1, 2023 23:00 HKT/SGT
|
|
|
Drilling at Congress Gold Mine Project Returns as high as 14.9 g/t Gold over 1.5m
Feb 1, 2023 23:00 HKT/SGT
|
|
|
ACROMETA Group Appoints Veteran Investor Mr. Levin Lee as Executive Chairman
Feb 1, 2023 16:00 HKT/SGT
|
|
|
Compact CO2 Capture System Receives "Awards for Excellence" at the 2022 Nikkei Excellent Products and Services Awards
Feb 1, 2023 16:52 JST
|
|
|
三菱重工、小型CO2回収装置が「2022年日経優秀製品・サービス賞」最優秀賞を受賞
Feb 1, 2023 15:20: JST
|
|
|
RHTLaw Asia strengthens Litigation & Dispute Resolution Practice through merger with ChangAroth Chambers
Feb 1, 2023 14:30 HKT/SGT
|
|
|
GenTwo Continues Growth Story, New Inflows of Over US$1 Billion
Feb 1, 2023 14:00 HKT/SGT
|
|
|
Society Pass (Nasdaq: SOPA) Engages ThinkEquity to Facilitate Stock Repurchase Program of Up to US$2 Million Commencing on 01 February 2023
Feb 1, 2023 14:00 HKT/SGT
|
|
|
Truescope Acquires US Firm Universal Information Services
Feb 1, 2023 12:30 HKT/SGT
|
|
|
マツダ、人事異動を発表
Feb 1, 2023 12:20: JST
|
|
|
Honda、小型耕うん機「サ・ラ・ダ FF300 20周年記念モデル」の受注開始
Feb 1, 2023 12:00: JST
|
|
|
富士通、世界最大のモバイル関連展示会「MWC Barcelona 2023」に出展
Feb 1, 2023 10:20: JST
|
|
|
欧康维视自研新药OT-101于中国完成完成受试者入组
Feb 1, 2023 10:02 HKT/SGT
|
|
|
歐康維視自研新藥OT-101於中國完成完成受試者入組
Feb 1, 2023 10:01 HKT/SGT
|
|
|
Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China
Feb 1, 2023 10:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|